Parkinson’s disease is a progressive brain disorder that gradually destroys the nerve cells responsible for controlling movement. It affects an estimated 10 million people worldwide, with projections suggesting that number will reach 25.2 million by 2050. The disease develops when neurons in a specific part of the brain die off over time, reducing levels of a chemical messenger called dopamine that your body needs to produce smooth, coordinated movement.
What Happens in the Brain
Deep in the midbrain sits a structure called the substantia nigra, home to neurons that produce dopamine. These neurons send long branches into a movement-control hub called the basal ganglia, where dopamine acts as a fine-tuning signal. It essentially turns down the volume on other brain signals, keeping your movements smooth and intentional rather than jerky or excessive.
In Parkinson’s, these dopamine-producing neurons progressively die. With less dopamine reaching the basal ganglia, the brain’s movement circuits lose their calibration. Signals from the motor cortex that would normally be modulated now flood through unchecked, creating the stiffness, slowness, and tremor that define the disease. By the time most people notice symptoms, roughly 60 to 80 percent of these neurons have already been lost.
At the cellular level, the damage involves a protein called alpha-synuclein. In healthy brains, this protein plays a normal role in nerve cell function. In Parkinson’s, it misfolds and clumps together into toxic clusters known as Lewy bodies. These clumps can spread from cell to cell, almost like an infection: misfolded alpha-synuclein enters a neighboring neuron, triggers the protein inside that cell to misfold as well, and the damage propagates through connected brain regions over months and years.
Early Warning Signs Before Movement Problems
Parkinson’s doesn’t start with a tremor. Years, sometimes more than a decade, before any movement symptoms appear, the disease quietly produces changes that are easy to dismiss or attribute to aging.
Loss of smell is one of the earliest. More than 50 percent of people with Parkinson’s experience a significantly reduced sense of smell, with another 35 percent having severe impairment. Chronic constipation is another early marker. A long-term study of nearly 6,800 men found that those who had fewer than one bowel movement per day were 4.5 times more likely to eventually develop Parkinson’s than those who had two or more daily.
REM sleep behavior disorder, where people physically act out vivid dreams by kicking, punching, or shouting during sleep, is particularly telling. Between 15 and 33 percent of Parkinson’s patients have this condition, and studies have shown that 40 to 50 percent of people diagnosed with REM sleep behavior disorder eventually develop Parkinson’s. None of these signs alone means you have Parkinson’s, but the combination of two or more over time can be significant.
The Four Cardinal Movement Symptoms
The hallmark symptoms of Parkinson’s are centered on how you move.
- Tremor: A rhythmic shaking, most noticeable when the hand is resting in your lap. It often starts on one side of the body. Some people also develop tremor when holding their arms outstretched or during movement.
- Rigidity: Muscles feel stiff and resist movement, even when someone else tries to bend your arm or leg. This can cause aching and make it harder to swing your arms when walking.
- Bradykinesia: A gradual slowing of spontaneous movement. Simple tasks like buttoning a shirt or getting out of a chair take noticeably longer. Movements also become smaller, so handwriting may shrink and facial expressions may flatten.
- Postural instability: Poor balance and coordination that develops as the disease progresses, increasing the risk of falls.
A formal diagnosis requires bradykinesia plus at least one of the other symptoms, typically rest tremor or rigidity. There is no single blood test or brain scan that confirms Parkinson’s. Neurologists diagnose it primarily through clinical examination, looking for the characteristic movement patterns and ruling out other causes. A specialized imaging scan called a DaTscan can help by showing reduced dopamine activity in the brain, but the clinical picture remains the cornerstone of diagnosis.
How the Disease Progresses
Parkinson’s follows a general five-stage progression, though the speed varies enormously from person to person. Some people remain in early stages for many years; others progress more quickly.
In stage 1, symptoms affect only one side of the body and are mild enough that daily life is barely disrupted. Stage 2 brings symptoms to both sides, though balance remains intact. By stage 3, balance problems emerge and physical movements slow further, but you can still live independently. Stage 4 involves severe limitations: walking is still possible but difficult, and daily tasks require help. Stage 5 means a person is unable to stand or walk without assistance and may be confined to a wheelchair or bed.
Most people spend years in the earlier stages, particularly with effective treatment. The non-motor symptoms, including depression, anxiety, cognitive changes, and sleep disruption, often become as impactful as the movement problems over time.
Who Gets Parkinson’s and Why
Parkinson’s results from a mix of genetic vulnerability and environmental exposure, and in most cases no single cause can be pinpointed. About 10 to 15 percent of people with Parkinson’s carry variants in a gene called GBA1, making it the most common genetic risk factor. Another gene, LRRK2, appears in 1 to 2 percent of cases overall but is far more common in certain populations: up to 30 percent of Ashkenazi Jewish individuals with Parkinson’s carry the LRRK2-G2019S variant, while it appears in only 0.1 percent of people of Asian descent with the disease.
Carrying these gene variants doesn’t guarantee you’ll develop Parkinson’s. Penetrance, the likelihood a carrier actually develops the disease, depends on other genetic factors and environmental exposures. Pesticide exposure, head injuries, and living in rural areas have all been linked to higher risk. On the protective side, one study found that regular use of common anti-inflammatory pain relievers (at least two pills per week for six months or more) was associated with a 66 percent lower risk of Parkinson’s among LRRK2 variant carriers. Men develop Parkinson’s about 1.5 times more often than women, and the average age of onset is around 60, though roughly 5 to 10 percent of cases begin before age 50.
How Parkinson’s Is Treated
No treatment can stop or reverse the underlying nerve cell loss, but medication can dramatically improve symptoms for years. The most effective drug is levodopa, a compound the brain converts directly into dopamine. It’s paired with a second medication, carbidopa, which prevents levodopa from breaking down in the bloodstream before it reaches the brain. This combination reduces the dose needed and cuts down on nausea. It can take several months to feel the full benefit.
Levodopa works well in the early and middle stages, but over time its effectiveness becomes less predictable. Many people experience “on-off” fluctuations, where the medication works for shorter periods and symptoms break through between doses. Involuntary movements called dyskinesias can also develop as a side effect of long-term use. Doctors adjust dosing schedules and sometimes add other medications to smooth out these fluctuations.
For people whose symptoms can no longer be well controlled with medication, deep brain stimulation (DBS) is an option. This surgical procedure involves implanting thin electrodes into specific brain areas and delivering continuous electrical pulses that modulate the faulty movement circuits. Candidates typically need to have had Parkinson’s for at least four to five years, show a clear response to levodopa, and be experiencing motor fluctuations that significantly affect daily life. DBS is particularly effective for tremor that doesn’t respond to medication, and it can also improve stiffness, slowness, freezing of gait, and some non-motor symptoms like sleep problems and urinary issues. It does not work well for balance problems or symptoms that levodopa itself cannot improve.
Living With Parkinson’s Over Time
Parkinson’s is a condition measured in decades, not months. Many people live 15 to 20 years or more after diagnosis, and the quality of those years depends heavily on how symptoms are managed. Regular exercise is one of the most consistently beneficial interventions. Structured physical activity, particularly aerobic exercise, balance training, and programs like boxing or dance designed for Parkinson’s, has been shown to slow functional decline and improve mobility.
Physical and occupational therapy help maintain independence as the disease progresses, teaching strategies for navigating daily tasks when movement becomes more difficult. Speech therapy addresses the voice and swallowing changes that affect many people in later stages. The disease touches nearly every system in the body over time, from digestion to mood to cognition, so care often involves a team of specialists rather than a single doctor.